Docosahexaenoic Acid on Breath Holding Spells in Children

Sherief Abd-Elsalam

Status and phase: Enrolling; Phase 3

Conditions: Breath Holding Attack

Treatments: Drug: DHA; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT03965988

breah holding

Details and patient eligibility

About

DHA on Breath Holding Spells

Full description

Effect of DHA on Breath Holding Spells

Enrollment: 60 estimated patients

Sex: All

Ages: 1 month to 5 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Children with newly diagnosed sprlls

Exclusion Criteria Other treatment as iron and piracetam

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

60 participants in 2 patient groups, including a placebo group

Docosahexaenoic Acid

Experimental group

Description:

Docosahexaenoic acid

Treatment:

Drug: DHA

Placebo drug

Placebo Comparator group

Description:

Placebo

Treatment:

Drug: Placebo